Evidence map›Paper›PMID 42818750›Full record

ArticleFrontiers in public health2026

National genomic surveillance of carbapenemase-producing

Mateja Pirs, Urška Kramar, Tina Triglav, Katja Strašek Smrdel, Andraž Celar Šturm, Lara Bezjak, Sandra Janezic

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mateja PirsInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Urška KramarNational Laboratory for Health, Environment and Food, Centre for Medical Microbiology, Maribor, Slovenia.
Tina TriglavInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Katja Strašek SmrdelInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Andraž Celar ŠturmInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Lara BezjakNational Laboratory for Health, Environment and Food, Centre for Medical Microbiology, Maribor, Slovenia.
Sandra JanezicNational Laboratory for Health, Environment and Food, Centre for Medical Microbiology, Maribor, Slovenia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The incidence of carbapenemase-producing (CP) Methods: WGS was performed using short-read sequencing. Bioinformatic analyses included identification of antimicrobial resistance (AMR) determinants, multilocus sequence typing (MLST), phylogroup typing, core genome multilocus sequence typing (cgMLST), assessment of genetic relatedness, and plasmid reconstruction using MOB-suite. Results: A total of 108 CP- Discussion: CP-

Indexed as

Bacterial Proteinsbeta-LactamasesEscherichia coliEscherichia coli InfectionsHumansMicrobial Sensitivity TestsMultilocus Sequence TypingPlasmidsSloveniaWhole Genome SequencingBacterial Proteinsbeta-LactamasescarbapenemasecarbapenemaseEscherichia coliplasmidpopulation structureWGS

Identifiers

PMID42818750
PMCPMC13623892

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.